fda approves first oral glp-1 obesity drug august 1 2025 weight loss pill New GLP-1 Pill Foundayo (Orforglipron)

70% white

Zhao, X., Wang, M., Wen, Z., Lu, Z., Cui, L., Fu, C., Xue, H., Liu, Y., & Zhang, Y

The GLPs share the same underlying mechanism of action, but they differ in terms of formulations, administration, injection devices and dosages

Today 21 (5), 802818

demonstrated that although the combination therapy (metformin 1000 mg BID + liraglutide 1.2 mg/day) resulted in a greater weight loss than liraglutide alone, both groups showed an increase in SHBG and a decrease in free testosterone, with no differences between the two treatment arms, thus suggesting that the effect on the biochemical hyperandrogenism of liraglutide may be partially independent of the extent of weight loss [60]

M., Unger, J., Karsbl, J